Sensorion Logo

Sensorion

ISIN

FR0012596468

Ticker

ALSEN

Sector

Health Care

Sub-Industry

Biotechnology

Country

France

Year Founded

2009

About Sensorion

Company Description

Sensorion’s mission is to offer innovative therapeutic solutions providing long-term improvements to people living with, or at risk of, inner ear disorders. Sensorion’s portfolio of solutions to unmet medical and social needs in inner ear disorders rests on three pillars – Restore, Treat, Prevent.

Restore
We aim to restore hearing by treating genetic diseases previously regarded as untreatable.

Treat
We aim to treat hearing disorders through innovative small molecule therapeutic solutions.

Prevent
We aim to prevent non-genetic hearing loss (e.g drug or surgery-related) through targeted therapeutic programs.

Headcount

34

Served Area

Worldwide

Headquarters

375 Rue du Professeur Joseph Blayac
34080, Montpellier
France

Insider Trades

Date Trading entity / Person Association Trade type Volume
11.04.2024 None Other Other EUR 1,752,605.82
11.04.2024 None Other Other EUR 999,999.63
13.02.2024 None Other Other EUR 9,599,999.85
08.02.2024 None Other Other EUR 6,999,999.57
08.08.2023 None Other Other EUR 12,999,999.88
03.08.2023 None Other Other EUR 7,000,000.00

Capital Markets Information

ISIN

FR0012596468

LEI

969500P0W8XJ9CGZDP97

Sub-Industry

Biotechnology

Listed Stock Exchange

Euronext Paris

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.